- News & Views
- Published:
Immunology
Licence to kill
Naturevolume 393, pages413–414 (1998)Cite this article
2879Accesses
325Citations
7Altmetric
When the body's own cells become infected, the immune system can take the extreme step of killing them to preserve the rest of the organism. It is no surprise that this potentially dangerous mechanism has to be kept under strict control, and onpages 4741,4782 and4803 of this issue, three groups suggest a new mechanism by which this control operates.
The need for helpers and the nature of this help have intrigued immunologists for years. The first model (Fig. 1b) suggested that T-helper and T-killer cells recognize their specific antigens simultaneously on the same APC, and that cytokines (such as interleukin-2) produced by the activated T-helper cell would act on the T killer and facilitate its response4,5. Although interleukin-2 can substitute for helper cells in some systems, there are two main problems with this model. First, it requires that two rare antigen-specific cells meet on the same antigen-bearing APC — an event that has an extremely low probability. Second, and more importantly, some killer responses can be elicited in the absence of helper cells6, implying that the need for help is conditional rather than absolute.
This is a preview of subscription content,access via your institution
Relevant articles
Open Access articles citing this article.
A universal reporter cell line for bioactivity evaluation of engineered cytokine products
- Jacqueline Mock
- ,Christian Pellegrino
- & Dario Neri
Scientific ReportsOpen Access24 February 2020
Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells
- Kamila Hladíková
- ,Vladimír Koucký
- … Anna Fialová
Journal for ImmunoTherapy of CancerOpen Access17 October 2019
Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis
- Costanza Casiraghi
- ,Ana Citlali Márquez
- … Marc Steven Horwitz
Scientific ReportsOpen Access10 September 2015
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
¥ 4,980
Prices may be subject to local taxes which are calculated during checkout

References
Ridge, J. P., Di Rosa, F. & Matzinger, P.Nature393, 474–478 (1998).
Bennett, S. R. M.et al.Nature393, 478–480 (1998).
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R. & Melief, C. J. M.Nature393, 480–483 (1998).
Keene, J. A. & Forman, J.J. Exp. Med.155, 768–782 (1982).
Mitchison, N. A. & O'Malley, C.Eur. J. Immunol.17, 1579–1583 (1987).
Buller, R. M., Holmes, K. L., Hugin, A., Frederickson, T. N. & Morse, H. C.Nature328, 77–79 (1987).
Guerder, S. & Matzinger, P. J.J. Exp. Med.176, 553–564 (1992).
Banchereau, J. & Steinman, R. M.Nature392, 245–252 (1998).
Sallusto, F. & Lanzavecchia, A.J. Exp. Med.179, 1109–1118 (1994).
Caux, C.et al.J. Exp. Med.180, 1263–1272 (1994).
Cella, M.et al.J. Exp. Med.184, 747–752 (1996).
Janeway, C. A. JCold Spring Harb. Symp. Quant. Biol.54, 1–13 (1989).
Author information
Authors and Affiliations
the Basel Institute for Immunology, Grenzacherstrasse 487, CH 4005, Basel, Switzerland
Antonio Lanzavecchia
- Antonio Lanzavecchia
Search author on:PubMed Google Scholar
Rights and permissions
About this article
Cite this article
Lanzavecchia, A. Licence to kill.Nature393, 413–414 (1998). https://doi.org/10.1038/30845
Issue date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
Development of Multi-epitope Based Subunit Vaccine Against Crimean-Congo Hemorrhagic Fever Virus Using Reverse Vaccinology Approach
- Md. Ashik Imran
- Md. Rubiath Islam
- Ajit Ghosh
International Journal of Peptide Research and Therapeutics (2022)
A universal reporter cell line for bioactivity evaluation of engineered cytokine products
- Jacqueline Mock
- Christian Pellegrino
- Dario Neri
Scientific Reports (2020)
Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells
- Kamila Hladíková
- Vladimír Koucký
- Anna Fialová
Journal for ImmunoTherapy of Cancer (2019)
Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis
- Costanza Casiraghi
- Ana Citlali Márquez
- Marc Steven Horwitz
Scientific Reports (2015)
CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells
- X Qiu
- C Klausen
- P C K Leung
Cell Death & Disease (2015)